{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:57:43Z","timestamp":1767175063515,"version":"build-2238731810"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13071-016-1618-y","type":"journal-article","created":{"date-parts":[[2016,6,6]],"date-time":"2016-06-06T08:37:52Z","timestamp":1465202272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Safety of concurrent treatment of cats with fluralaner and emodepsid\u2013praziquantel"],"prefix":"10.1186","volume":"9","author":[{"given":"Feli M.","family":"Walther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer K. A.","family":"Roepke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,6]]},"reference":[{"key":"1618_CR1","unstructured":"European Commission. Community register of veterinary medicinal products, Product information, Annex 1 Summary of product characteristics Bravecto spot-on solution for cats. 2016. http:\/\/ec.europa.eu\/health\/documents\/community-register\/html\/v158.htm ."},{"key":"1618_CR2","doi-asserted-by":"crossref","unstructured":"Kilp S, Ramirez D, Allan MJ, Roepke RKA. Comparative pharmacokinetics of fluralaner in dogs and cats following topical or single intravenous administration. Parasit Vectors. in press.","DOI":"10.1186\/s13071-016-1564-8"},{"key":"1618_CR3","volume-title":"Community register of veterinary medicinal products, Product information, Annex 1 Summary of product characteristics Profender","author":"European Commission","year":"2010","unstructured":"European Commission. Community register of veterinary medicinal products, Product information, Annex 1 Summary of product characteristics Profender. 2010. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/veterinary\/000097\/WC500063851.pdf ."},{"key":"1618_CR4","volume-title":"Community register of veterinary medicinal products, Product information, Annex 1 Summary of product characteristics Bravecto chewable tablets for dogs","author":"European Commission","year":"2014","unstructured":"European Commission. Community register of veterinary medicinal products, Product information, Annex 1 Summary of product characteristics Bravecto chewable tablets for dogs. 2014. http:\/\/ec.europa.eu\/health\/documents\/community-register\/html\/v158.htm ."},{"key":"1618_CR5","unstructured":"European Commission. Community register of veterinary medicinal products, Product information, Annex 1 Summary of product characteristics Bravecto spot-on solution for dogs. 2016. http:\/\/ec.europa.eu\/health\/documents\/community-register\/html\/v158.htm"},{"key":"1618_CR6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1756-3305-7-105","volume":"7","author":"FM Walther","year":"2014","unstructured":"Walther FM, Fisara P, Allan MJ, Roepke RKA, Nuernberger MC. Safety of the concurrent treatment of dogs with Bravecto\u2122 (fluralaner) and Scalibor\u2122 protectorband (deltamethrin). Parasit Vectors. 2014;7:105.","journal-title":"Parasit Vectors"},{"key":"1618_CR7","first-page":"481","volume":"7","author":"FM Walther","year":"2014","unstructured":"Walther FM, Fisara P, Allan MJ, Roepke RKA, Nuernberger MC. Safety of concurrent treatment of dogs with fluralaner (Bravecto\u2122) and milbemycin oxime \u2013 praziquantel. Parasit Vectors. 2014;7:481.","journal-title":"Parasit Vectors"},{"key":"1618_CR8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s13071-015-1123-8","volume":"8","author":"FM Walther","year":"2015","unstructured":"Walther FM, Allan MJ, Roepke RKA. Plasma pharmacokinetic profile of ivermectin and fluralaner (Bravecto\u2122) following concurrent administration to dogs. Parasit Vectors. 2015;8:508.","journal-title":"Parasit Vectors"}],"updated-by":[{"DOI":"10.1186\/s13071-016-1652-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000}}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-016-1618-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T11:48:32Z","timestamp":1498304912000},"score":1,"resource":{"primary":{"URL":"http:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-016-1618-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,6]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1618"],"URL":"https:\/\/doi.org\/10.1186\/s13071-016-1618-y","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,6]]},"article-number":"322"}}